A novel MYB::PAIP1 oncogenic fusion in pediatric blastic plasmacytoid dendritic cell neoplasm (BPDCN) is dependent on BCL2 expression and is sensitive to venetoclax. This evidence concerns the gene MYB and CD4+/CD56+ hematodermic neoplasm.